dc.date.accessioned | 2019-12-06T20:57:47Z | |
dc.date.available | 2019-12-06T20:57:47Z | |
dc.date.created | 2019-12-06T20:57:47Z | |
dc.date.issued | 2019 | |
dc.identifier | https://hdl.handle.net/20.500.12866/7407 | |
dc.identifier | https://doi.org/10.1177/1533317519869709 | |
dc.description.abstract | OBJECTIVES: To assess the psychometric properties of the Peruvian version of the Rowland Universal Dementia Assessment Scale (RUDAS-PE) to discriminate controls from patients with mild cognitive impairment (MCI) and early dementia (ED) in a population with a mid-level education. METHODS: A total of 133 patients from a memory clinic were administered the RUDAS-PE, INECO Frontal Screening, Addenbrooke's Cognitive Examination, and Mini-Mental State Examination. Results were compared against a neuropsychological evaluation (gold standard). Validity measures, internal consistency, and concurrent validity were calculated. RESULTS: Cronbach's alpha was 0.68; Pearson's ratio was 0.79 (P < .01). The area under the receiver-operating characteristics curve of the RUDAS to discriminate between ED and MCI was 89.0% (optimal cutoff at <21), whereas between MCI and controls, it was 99.0% (optimal cutoff at <24). CONCLUSIONS: The RUDAS-PE has acceptable psychometric properties performing well in its ability to discriminate controls from patients with MCI and ED. | |
dc.language | eng | |
dc.publisher | SAGE Publications | |
dc.relation | American Journal of Alzheimer's Disease and Other Dementias | |
dc.relation | 1938-2731 | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Addenbrooke Cognitive Examination | |
dc.subject | aged | |
dc.subject | Alzheimer disease | |
dc.subject | Alzheimer's disease | |
dc.subject | Alzheimer’s disease | |
dc.subject | aminotransferase | |
dc.subject | Article | |
dc.subject | Beck Depression Inventory | |
dc.subject | brief cognitive tests | |
dc.subject | Clinical Dementia Rating | |
dc.subject | cognitive impairment | |
dc.subject | computer assisted tomography | |
dc.subject | controlled study | |
dc.subject | creatinine | |
dc.subject | cyanocobalamin | |
dc.subject | dementia | |
dc.subject | dementia assessment | |
dc.subject | diagnostic accuracy | |
dc.subject | diagnostic test accuracy study | |
dc.subject | disorders of higher cerebral function | |
dc.subject | DSM-5 | |
dc.subject | education | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | female | |
dc.subject | folic acid | |
dc.subject | free liothyronine index | |
dc.subject | free thyroxine index | |
dc.subject | glucose | |
dc.subject | gold standard | |
dc.subject | human | |
dc.subject | INECO Frontal Screening | |
dc.subject | Likert scale | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | mild cognitive impairment | |
dc.subject | neurocognitive disorders | |
dc.subject | neuropsychological test | |
dc.subject | neuropsychological tests | |
dc.subject | nuclear magnetic resonance imaging | |
dc.subject | outcome assessment | |
dc.subject | Peru | |
dc.subject | pilot study | |
dc.subject | predictive value | |
dc.subject | psychometry | |
dc.subject | questionnaire | |
dc.subject | receiver operating characteristic | |
dc.subject | Rey auditory verbal learning test | |
dc.subject | Rowland Universal Dementia Assessment Scale | |
dc.subject | scoring system | |
dc.subject | sensitivity and specificity | |
dc.subject | thyrotropin | |
dc.subject | trail making test | |
dc.subject | urea | |
dc.subject | validation process | |
dc.subject | Wechsler adult intelligence scale | |
dc.subject | Wechsler memory scale | |
dc.subject | Wisconsin Card Sorting Test | |
dc.title | Validation of the RUDAS in Patients With a Middle-Level Education in Lima, Peru. | |
dc.type | info:eu-repo/semantics/article | |